Friedreich's ataxia pathophysiology

Revision as of 18:00, 15 April 2019 by Aditya Ganti (talk | contribs) (Created page with "__NOTOC__ {{Friedreich's ataxia}} {{CMG}} ; {{AE}} ==Overview== ==Pathophysiology== ===Pathogenesis and genetics=== It is understood that Friedreich’s ataxia is the result...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Friedreich's ataxia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Friedreich's ataxia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Friedreich's ataxia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Friedreich's ataxia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Friedreich's ataxia pathophysiology

CDC on Friedreich's ataxia pathophysiology

Friedreich's ataxia pathophysiology in the news

Blogs on Friedreich's ataxia pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Friedreich's ataxia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief:

Overview

Pathophysiology

Pathogenesis and genetics

It is understood that Friedreich’s ataxia is the result of a homozygous guanine-adenine-adenine (GAA) trinucleotide repeat expansion on chromosome 9q13 that causes a transcriptional defect of the frataxin gene. Frataxin is a small mitochondrial protein and deficiency of frataxin is responsible for all clinical and morphological manifestations of Friedreich’s ataxia. The severity of the disease is directly related to the length of the trinucleotide repeat expansion and long expansions lead to early onset, severe clinical illness, and death in young adult life. Patients with short trinucleotide repeat expansion have a later onset and a more benign course and even some of them are not diagnosed during life. Friedreich’s ataxia is transmitted in autosomal recessive pattern. Because the frataxin protein has multiple functions in the normal state, the exact role of frataxin deficiency in the pathogenesis of Friedreich's ataxia is still unclear. These functions include: Biogenesis of iron-sulfur clusters Iron chaperoning Iron storage Control of iron-mediated oxidative tissue damage

Associated Conditions

Conditions associated with friedreich’s ataxia include:

Hypertrophic cardiomyopathy Diabetes mellitus Scoliosis Distal wasting Optic atrophy Sensorineural deafness Sleep apnea Pes cavus in 55% to 75% of cases

Gross Pathology

On gross pathology involvement of spinal cord, cerebellum, and heart are characteristic findings of Friedreich's ataxia.

Spinal cord lesions include:

Decreased transverse diameter of the spinal cord at all levels The thinning is especially evident in the thoracic region Thin and gray dorsal spinal roots Smallness and gray discoloration of the dorsal column Thin and gray gracile and cuneate fasciculi Fiber loss in the anterolateral fields corresponding to spinocerebellar and corticospinal tracts

Cerebellum lesions include:

Atrophy of the dentate nuclei and its efferent fibers

Heart findings include:

Increased heart weight Increased thickness of left and right ventricular walls and interventricular septum Dilatation of the ventricles “Marble”-like discoloration of the myocardium

Microscopic Pathology

On microscopic histopathological analysis, involvement of spinal cord, cerebellum, heart and pancreas are characteristic findings of Friedreich's ataxia.

Spinal cord

Friedreich’s ataxia mostly affects the dorsal root ganglia (DRG) of the spinal cord. It affects the entire DGR but is most prominent in subcapsular regions. Cell stains in samples of DGN reveal: An overall reduction in the size of ganglion cells The absence of very large neurons and large myelinated fibers Clusters of nuclei representing “residual nodules” that indicate an invasion-like entry of satellite cells into the cytoplasm of neurons. Progressive destruction of neuronal cytoplasm in cytoskeletal stains, such as for class-III-β-tubulin Greatly thickened satellite cells Residual nodules remain strongly reactive with anti-S100α in the satellite cells Increased ferritin immunoreactivity in satellite cells

Cerebellum

Friedreich’s ataxia mostly affects the dentate nucleus of cerebellum Cell stains in samples of cerebellum reveal: The absence of very large neurons Severe loss of γ-aminobutyric acid (GABA)-containing terminals in the immunostaining with an antibody to glutamic acid decarboxylase (GAD) Grumose degeneration in the immunostaining with anti-GAD Punctate reaction product in areas known to be rich in mitochondria, namely, neuronal cytoplasm and synaptic terminals Frataxin-deficient mitochondria

Heart

Cell stains in samples of heart reveal: Collections of tiny reactive inclusions in a small percentage of cardiomyocytes that are arranged in parallel with myofibrils in the iron stains Electron-dense inclusions in mitochondria Myocardial fiber necrosis and an inflammatory reaction in the severe cases of cardiomyopathy

Pancreas

Cell stains in samples of pancreas reveal: Lose of the sharp demarcation of the synaptophysin-positive islets of pancreas The “fade” appearance of the β-cells into the surrounding exocrine pancreas